No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data

Home COUNTRY ITALY

Mediobanca-promoted Spac ALP.I announces a business combination with Antares Vision

bebeezby bebeez
December 20, 2018
Reading Time: 3 mins read
in ITALY, PRIVATE EQUITY
Share on LinkedinShare on FacebookShare on Twitter

antaresLess then one year after oisting at the Aim Italia market last February 1st and after having raised 100 million euros from investors, ALP.I spa, the Special Purpose Acquisition Company (SPAC) promoted by Mediobanca together with Stefano Giambelli, Roberto Marsella, Massimo Perona and Stefano Rangone (see here a previous post by BeBeez), announced it will make a business combination with Antares Vision, a global leader in visual inspection, tracking solutions and data management for the pharmaceutical sector, in order to list the company at the Italian Stock Exchange (see here the press release).

More in detail, ALP.I will invest 70 million euros for a 12% stake in the company, while the remaining 30 million euros will be distributed to ALP.I investors net of potential withdrawals. Of thos 70 million euros, 50 millions will be invested subscribing a capital increase in the company while the remaining 20 millions will be used to buy Antares Vision’s shares from actual major shareholder Regolo. Antares Vision’s general meeting voting about the business combination will be hold next February.

The announcement about the business combination follows a recent capital increase in Antares Vision subscribed by Sargas, an investment veichle controlled by  the well known pasta entrepreneur Guido Barilla together with other investors such as Inpar Investment Fund, H14 controlled by the Berlusconi family and Antonio Belloni. Sargas will own a 14% stake after the combination.

Antares Vision, founded in 2007 by  opto-electronic engineers Emidio Zorzella and Massimo Bonardi, has over 2000 installations on packaging lines in over 200 pharmaceutical factories in Italy and around the world and is the sole or main supplier of 10 of the 20 largest pharmaceutical groups in the world. The two entrepreneurs bought back a 21.1% stake in the company in May 2017 from Fondo Italiano di Investimento, that was then managed by  the eponymous managemnt company, which had entered Antares Vision capital in July 2012 (see here a previous post by BeBeez).

Antares Vision reached 81.3 million euros in revenues in 2017 and 20.7 millions in ebitda with a net positive financial position (net liquidity) of 4.2 millions. Thanks to new cash Antares Vision will be ready to evaluate acquisitions as the market is rather fragmented.  As for financial figures, reasearch analysis by Mediobanca Securities and  Equita sim is available already for investors since the announcement of the business combination,

Moreover some other news have been announced as for the structure of ALP.I: the SPac’s promoters have aligned better their interests to the ones of their investors as they have eliminated all the triggers for their special shares  (originally fixed at 11, 12 and 13 euro per share) and fixing a unique trigger at 13,5 euro per share, extending the divestment period to 5 years.  This means that AKP.I’s promoters will convert their special shares into ordinary shares only after ALP.I’s investors will have received the maximum number of shares  from their warrants (when shares will have reached the price of 13 euro per share) and then obtained a total return of more than 50%.

Moreover it has been decided to leave stable the nbumber of warrants and shares for ALP.I’s investors even if ALP.I’s investment has been reduced by 30% , which means that leverage in favour of each ALP.I’s investor has been raised.

For the deal ALP.I has been supported by financial advisor Mediobanca, by BonelliErede law firm, Honigman Miller Schwartz and Cohn (legal due diligence in the US), New Deal Advisors (financial due diligence) and auditor PricewaterhouseCoopers. Antares Vision was advised by Rothschild & Co, Orsingher Ortu law firm and auditor EY. Equita sim acts as the nominated adviser and specialist.

Sign up to our newsletter

Subscribe to our daily newsletter, please fill out the form by clicking the button.

GO TO THE FORM
Previous Post

Italy’s angels & incubators and venture capital weekly roundup. News from LVenture, CrowdInvest Italia, Indaco Venture

Next Post

Italy’s angels & incubators and venture capital weekly roundup. News from Endostart, Projects Co-living, Innova Venture, Metis Precision Medicine, Concrete, StartupItalia

Related Posts

FRANCE

European Hotel Transactions Surge in 2024 Marking a Turning Point for Investment

April 23, 2025
GREEN

🎥Foodtech investing: ‘You can’t escape the fundamentals. You have to produce something that adds significant value’

October 24, 2024
BENELUX

Corteva Catalyst exec on investing in agrifoodtech startups: ‘We’re trying to be very intentional…’

October 24, 2024

CIAO LUCA

Related Posts

FRANCE

European Hotel Transactions Surge in 2024 Marking a Turning Point for Investment

April 23, 2025
GREEN

🎥Foodtech investing: ‘You can’t escape the fundamentals. You have to produce something that adds significant value’

October 24, 2024
BENELUX

Corteva Catalyst exec on investing in agrifoodtech startups: ‘We’re trying to be very intentional…’

October 24, 2024

Next Post

Italy's angels & incubators and venture capital weekly roundup. News from Endostart, Projects Co-living, Innova Venture, Metis Precision Medicine, Concrete, StartupItalia

Deals on non-performing exposures topped 101 bn euros in Italy in 2018. New deals have been already announced for at least other 21 bn

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart

© 2025 JNews - Premium WordPress news & magazine theme by Jegtheme.